AbbVie, Genmab win FDA label expansion for Epkinly in follicular lymphoma
The U.S. Food and Drug Administration (FDA) on Tuesday announced the approval of Epkinly, a bispecific antibody developed...
Tag: ABBV
Big pharma hits a record high as FDA picks new drug regulator
Shares of global drug companies reached a record high after the U.S. Food and Drug Administration (FDA) announced the...
Ironwood surges after Q3 beat; raised outlook for AbbVie-partnered Linzess
Shares of Ironwood Pharmaceuticals (IRWD) climbed ~34% on Monday after the company well exceeded Street forecasts with its...
FDA to remove “black box” warnings on hormone therapies for menopause
Marking a pivotal moment in women’s health, the U.S. Food and Drug Administration (FDA) on Monday initiated actions to...
Ironwood wins FDA label expansion for bowel disease drug developed with AbbVie
The U.S. Food and Drug Administration on Wednesday approved Linzess (linaclotide), developed by Ironwood Pharmaceuticals...
AbbVie raises 2025 EPS guidance and signals strong pipeline milestones into 2026
Earnings Call Insights: AbbVie Inc. (ABBV) Q3 2025 CEO Robert Michael stated that "AbbVie's business continues to perform...
AbbVie boosts 2025 EPS guidance but still falls short of consensus
While AbbVie (ABBV) raised its 2025 non-GAAP EPS guidance on Friday, it still falls short of the consensus figure. Shares...
Earnings Snapshot: AbbVie tops Q3 estimates; raises FY profit outlook
AbbVie: Deep Discount Before Earnings AbbVie: "Strong Buy" On Rinvoq Expansions And Immunology Pipeline Addition AbbVie:...
AbbVie in charts: Revenues from Humira -55%, Skyrizi +47%, Rinvoq +35% Y/Y
Seeking AlphaSeeking AlphaSeeking AlphaSeeking Alpha
AbbVie raises dividend by 5.5%
AbbVie (ABBV) declared $1.73/share quarterly dividend, 5.5% increase from prior dividend of $1.64. Forward yield...